Behavioral
Evolve Health, P.C.
Evolve Health, P.C. was paid $3.71M by Medicaid between Jan 2018 and Dec 2024, across 8 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 34% of everything it billed.
33Billing provider infoEVOLVE HEALTH, P.C.
QUINCY, MA 02171
QUINCY, MA 02171
33aNPI1760887434assigned 10/23/2014
33bProvider typeAddiction (Substance Use Disorder) Psychologist
28Total paid$3.71M
24GClaims104,508
24DCodes billed8
24AFirst – last monthJan 2018 – Dec 2024
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 18,201 | $295K | |
| 2019 | 19,642 | $639K | |
| 2020 | 26,425 | $985K | |
| 2021 | 21,992 | $874K | |
| 2022 | 7,315 | $347K | |
| 2023 | 8,978 | $475K | |
| 2024incomplete | 1,955 | $93K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 16,362 | 5,885 | $1.28M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 26% | 26,968 | 8,920 | $981K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 20% | 16,764 | 5,442 | $757K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 15% | 12,628 | 4,809 | $568K |
| 82575 | 3.3% | 18,402 | 5,838 | $122K | |
| 84311 | <1% | 4,219 | 1,488 | $1K | |
| 81003 | <1% | 4,584 | 1,619 | $177.54 | |
| 83986 | <1% | 4,581 | 1,621 | $162.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSAYEED-SHAH, UMER (PRESIDENT)